Anji Pharmaceuticals Funding: $70M Raised, Series B (2021)
Anji Pharmaceuticals is based in Cambridge, MA. It has raised $70M in total funding. Latest round: Series B. Backed by CR Capital.
Anji Pharmaceuticals funding overview
Anji Pharmaceuticals is based in Cambridge, MA. Anji Pharmaceuticals has raised $70M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in September 2021. The round record for Anji Pharmaceuticals runs through 2021; nothing later has been disclosed. Investors on record include CR Capital.
Anji Pharmaceuticals at a glance
Total raised
$70M
Latest round
Series B
Latest round date
September 2021
Headquarters
Cambridge, MA
Notable investors
CR Capital
Frequently asked about Anji Pharmaceuticals funding
How much has Anji Pharmaceuticals raised?
Anji Pharmaceuticals has raised $70M in total disclosed funding across the rounds on record.
Who has invested in Anji Pharmaceuticals?
CR Capital are named among the investors backing Anji Pharmaceuticals.
What was the latest Anji Pharmaceuticals funding round?
The most recent disclosed round is a Series B, announced in September 2021.
Where is Anji Pharmaceuticals based?
Anji Pharmaceuticals is based in Cambridge, MA.
When did Anji Pharmaceuticals last raise?
The last disclosed Anji Pharmaceuticals round closed in September 2021 at Series B.
Every Anji Pharmaceuticals figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Cambridge at a similar stage.
